SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen
BIIB 178.14-0.5%3:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harold Engstrom who wrote (571)1/22/1998 3:07:00 PM
From: Scott   of 1686
 
Please fill us in when you get an answer. Note: the Stryker safety data would not be very relevant to Biogen's use. Stryker uses it in an insoluble paste that is globbed onto or into a fracture. Nothing gets into the blood. The only tissue that feels the effects is the area of bone touched by the paste. Biogen/CBM injects it as a liquid into the bloodstream, so it hits every organ in the body at significant levels. Big difference in safety considerations.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News